Turmeric Acquisition Corp. is a special purpose acquisition company (SPAC) that raised $85M in its initial public offering in October 2020. The company is listed on the Nasdaq with the common shares trading under the symbol “TMPM” and is targeting a merger with a biopharmaceutical company developing novel therapies for its initial business combination.
- Compensation Committee Charter
- Audit Committee Charter
- Code of Conducts and Ethics
- Nominating and Corporate Governance Committee Charter
- TAC Class A – PFIC Annual Information Statement